New CFO to BioGaia

Alexander Kotsinas will start the position as Chief Financial Officer at BioGaia 5 November 2019. Until the end of the year, he will work in parallel with Margareta Hagman, who after many years at BioGaia will resign from her position.

“I have had 23 fantastic years at BioGaia and an incredible journey with the company, but now it is time for me to move on,” says Margareta Hagman, Executive Vice President Accounting, Finance and Investor Relations at BioGaia.

Alexander has a long and broad experience as CFO. Currently he holds a position at Lowell. Other work experiences include positions at Nexttrobe, Q-Med, Life Europe, Tre, Investor and Ericsson.

Latest press releases from BioGaia
23.10.2019 BioGaia AB Interim management statement 1 January-30 September 2019
15.10.2019 BioGaia’s probiotic effective as adjunct in patients with Helicobacter pylori infection
10.10.2019 Reduced sales due to delivery delays

For additional information please contact
Isabelle Ducellier, Chief Executive Officer, telephone: +46 8 555 293 00

BioGaia is an innovative Swedish healthcare company that develops, markets and sells probiotic products with documented health benefits. The products are sold through local distribution partners in around 100 countries worldwide. The class B share of the Parent Company BioGaia AB is quoted on the Mid Cap segment of Nasdaq Stockholm. www.biogaia.com